vimarsana.com

Latest Breaking News On - Efficient nonclinical inhalation toxicology - Page 1 : vimarsana.com

Ampio Pharmaceuticals Inc [AMPE] gain 13 21% so far this year What now?

Brandon Evans March 31, 2021 Ampio Pharmaceuticals Inc. [AMEX: AMPE] closed the trading session at $1.80 on 05/26/21. The day’s price range saw the stock hit a low of $1.75, while the highest price level was $1.86. The company report on May 21, 2021 that Ampio Pharmaceuticals to Present Poster at the International Society for Aerosols in Medicine (ISAM) 23rd International Congress. The company’s findings will be showcased to over 400 clinicians, respiratory health and critical care professionals, aerosol scientists, engineers, product development and regulatory experts. Ampio Pharmaceuticals (NYSE American: AMPE), a clinical stage biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, announced details on the company’s poster presentation, “Regulatory Decisions during COVID-19: Efficient Nonclinical Inhalation Toxicology for a Clinical Program,” being given at the 23rd International Congress o

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.